A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple Myeloma

NCT05730036 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

410

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed Refractory Multiple Myeloma (RRMM)

Interventions

DRUG: Linvoseltamab
DRUG: Elotuzumab
DRUG: Pomalidomide
DRUG: Dexamethasone

Sponsor

Regeneron Pharmaceuticals